K Furukawa, DG Harrison, D Saleh, H Shennib, FP Chagnon and A Giaid
Department of Pathology, Montreal General Hospital, Quebec, Canada.

The nasal mucosa plays an important role in defense of the lung against harmful agents. It has been suggested that this is partly mediated by the production of nitric oxide (NO). We have investigated the localization of the messenger ribonucleic acids (MRNAs) for human endothelial NO synthase (Type III NOS) and inducible NO synthase (Type II NOS) and the immunoreactivities of these enzymes in human nasal mucosa by immunohistochemistry, in situ hybridization, and reduced nicotinamide adenine diphosphate (NADPH) diaphorase histochemistry. Inferior nasal turbinates were obtained from 27 patients at the time of surgery for local disease. Strong immunostaining for Type III NOS was localized to vascular endothelium, surface epithelium, and submucosal glands in all subjects. Moderate immunostaining for Type II NOS was seen in surface epithelium; glandular, inflammatory, and vascular endothelial cells; and smooth-muscle cells in the specimens from patients with chronic rhinitis only. In situ hybridization showed expression of the mRNA for Type III NOS in similar sites to those shown by immunohistochemistry, whereas the mRNA for Type II NOS was predominantly localized to inflammatory cells. The sites of NOS expression were further confirmed by NADPH histochemical staining. These findings demonstrate the cellular expression of NOS in the human nasal mucosa and suggest a possible role for Types II and III NO synthase in the regulation of blood flow, nasal secretion, and ciliary movement in health and disease.

This article has been cited by other articles:

				J. Choi, L. A. Hoffman, G. W. Rodway, and J. M. Sethi Markers of lung disease in exhaled breath: nitric oxide. Biol Res Nurs, April 1, 2006; 7(4): 241 - 255. [Abstract] [PDF]

				H. Nakano, H. Ide, T. Ogasa, S. Osanai, M. Imada, S. Nonaka, K. Kikuchi, and J. Iwamoto Ambient oxygen regulates epithelial metabolism and nitric oxide production in the human nose J Appl Physiol, July 1, 2002; 93(1): 189 - 194. [Abstract] [Full Text] [PDF]

				D. C. Chambers, D. A. Carpenter, and J. G. Ayres Exchange dynamics of nitric oxide in the human nose J Appl Physiol, November 1, 2001; 91(5): 1924 - 1930. [Abstract] [Full Text] [PDF]

				H. NAKANO, H. IDE, M. IMADA, S. OSANAI, T. TAKAHASHI, K. KIKUCHI, and J. IWAMOTO Reduced Nasal Nitric Oxide in Diffuse Panbronchiolitis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2218 - 2220. [Abstract] [Full Text]

				W. STEUDEL, M. KIRMSE, J. WEIMANN, R. ULLRICH, J. HROMI, and W. M. ZAPOL Exhaled Nitric Oxide Production by Nitric Oxide Synthase-deficient Mice Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1262 - 1267. [Abstract] [Full Text] [PDF]

				W. E. Holden, J. P. Wilkins, M. Harris, H. A. Milczuk, and G. D. Giraud Temperature conditioning of nasal air: effects of vasoactive agents and involvement of nitric oxide J Appl Physiol, October 1, 1999; 87(4): 1260 - 1265. [Abstract] [Full Text] [PDF]

				J O N Lundberg and E Weitzberg Nasal nitric oxide in man Thorax, October 1, 1999; 54(10): 947 - 952. [Full Text]

				J. M. Chatkin, W. Qian, P. A. McClean, N. Zamel, J. Haight, and P. Silkoff Nitric Oxide Accumulation in the Nonventilated Nasal Cavity Arch Otolaryngol Head Neck Surg, June 1, 1999; 125(6): 682 - 685. [Abstract] [Full Text] [PDF]

				P. Murtz, L. Menzel, W. Bloch, A. Hess, O. Michel, and W. Urban LMR spectroscopy: a new sensitive method for on-line recording of nitric oxide in breath J Appl Physiol, March 1, 1999; 86(3): 1075 - 1080. [Abstract] [Full Text] [PDF]

				X.-P. Gao, S. R. Akhter, and I. Rubinstein Ovalbumin increases macromolecular efflux from the in situ nasal mucosa of allergic hamsters J Appl Physiol, January 1, 1998; 84(1): 169 - 176. [Abstract] [Full Text] [PDF]